Serzone Related Published Studies
Well-designed clinical trials related to Serzone (Nefazodone)
Patient preference as a moderator of outcome for chronic forms of major depressive disorder treated with nefazodone, cognitive behavioral analysis system of psychotherapy, or their combination. [2009.03]
A preliminary trial: double-blind comparison of nefazodone, bupropion-SR, and placebo in the treatment of cannabis dependence. [2009.01]
Nefazodone in the treatment of generalized social phobia: a randomized, placebo-controlled trial. [2007.02]
Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not. [2005.05]
Nefazodone in out-patient treatment of inhaled cocaine dependence: a randomized double-blind placebo-controlled trial. [2005.04]
Efficacy screening trials of paroxetine, pentoxifylline, riluzole, pramipexole and venlafaxine in cocaine dependence. [2005.03]
Combination treatment with nefazodone and cognitive-behavioral therapy for relapse prevention in alcohol-dependent men: a randomized controlled study. [2004.10]
A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder: a preliminary study. [2004.06]
Nefazodone treatment of comorbid alcohol dependence and major depression. [2004.03]
Comparative CYP3A4 inhibitory effects of venlafaxine, fluoxetine, sertraline, and nefazodone in healthy volunteers. [2004.02]
Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder. [2004]
Pharmacokinetic and pharmacodynamic interactions of oral midazolam with ketoconazole, fluoxetine, fluvoxamine, and nefazodone. [2003.11]
Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression. [2003.10.15]
Does nefazodone improve both depression and Parkinson disease? A pilot randomized trial. [2003.10]
Efficacy of nefazodone in the treatment of neuroleptic induced extrapyramidal side effects: a double-blind randomised parallel group placebo-controlled trial. [2003.06]
The effects of psychotherapy, nefazodone, and their combination on subjective assessment of disturbed sleep in chronic depression. [2003.03.15]
Nefazodone decreases anxiety during marijuana withdrawal in humans. [2003.01]
Continuation treatment of chronic depression: a comparison of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination. [2003]
Sexual function and satisfaction in the treatment of chronic major depression with nefazodone, psychotherapy, and their combination. [2002.08]
Differential effects of nefazodone and cognitive behavioral analysis system of psychotherapy on insomnia associated with chronic forms of major depression. [2002.06]
Randomised controlled study of sleep after nefazodone or paroxetine treatment in out-patients with depression. [2002.06]
Symptomatic and syndromal anxiety in chronic forms of major depression: effect of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination. [2002.05]
Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination. [2002.01.15]
Nefazodone in psychotic unipolar and bipolar depression: a retrospective chart analysis and open prospective study on its efficacy and safety versus combined treatment with amitriptyline and haloperidol. [2002]
A randomized, double-blind controlled comparison of nefazodone and paroxetine in the treatment of depression: safety, tolerability and efficacy in continuation phase treatment. [2001.09]
Opposite effects of nefazodone in two human models of anxiety. [2001.08]
Antidepressants and ejaculation: a double-blind, randomized, placebo-controlled, fixed-dose study with paroxetine, sertraline, and nefazodone. [2001.06]
Compounds with affinity for serotonergic receptors in the treatment of premenstrual dysphoria: a comparison of buspirone, nefazodone and placebo. [2001.05]
Which depressed patients respond to nefazodone and when? [2001.03]
Loratadine and terfenadine interaction with nefazodone: Both antihistamines are associated with QTc prolongation. [2001.03]
Reemergence of sexual dysfunction in patients with major depressive disorder: double-blind comparison of nefazodone and sertraline. [2001.01]
A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. [2000.05.18]
Well-designed clinical trials possibly related to Serzone (Nefazodone)
Comparison of substance use milestones in cannabis- and cocaine-dependent
patients. [2012]
The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease. [2011.10]
Antidepressants for major depressive disorder and dysthymic disorder in patients
with comorbid alcohol use disorders: a meta-analysis of placebo-controlled
randomized trials. [2011]
Efficacy of antidepressants for dysthymia: a meta-analysis of placebo-controlled
randomized trials. [2011]
Treatment of depression in patients from ethnic minority groups in the Netherlands. [2010.07]
Differential effects of treatments for chronic depression: a latent growth model reanalysis. [2010.06]
Dyadic discord at baseline is associated with lack of remission in the acute treatment of chronic depression. [2010.03]
Managing the patient with co-morbid depression and an anxiety disorder. [2008]
Severity and duration of depression, not personality factors, predict short term outcome in the treatment of major depression. [2007.12]
Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. [2007.04.18]
Effects of different doses of venlafaxine on serotonin and norepinephrine reuptake in healthy volunteers. [2007.02]
Dropouts versus completers among chronically depressed outpatients. [2007.01]
Combination treatment for acute depression is superior only when psychotherapy is added to medication. [2007]
[Combination treatment with SSRI and cognitive behavior therapy for relapse prevention of alcohol-dependent men. Results of a randomized, controlled multicenter therapeutic study] [2005.03]
Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients. [2005.02]
Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial. [2004.12]
Therapeutic reactance as a predictor of outcome in the treatment of chronic depression. [2003.12]
Therapeutic alliance in depression treatment: controlling for prior change and patient characteristics. [2003.12]
Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma. [2003.11.25]
Correlation of subjective and objective sleep measurements at different stages of the treatment of depression. [2003.09.30]
Patient's therapeutic skill acquisition and response to psychotherapy, alone or in combination with medication. [2003.05]
Other research related to Serzone (Nefazodone)
Triamcinolone acetonide induced secondary adrenal insufficiency related to impaired CYP3A4 metabolism by coadministration of nefazodone. [2010.07]
Select comorbid personality disorders and the treatment of chronic depression with nefazodone, targeted psychotherapy, or their combination. [2009.10]
Redistribution of slow wave activity of sleep during pharmacological treatment of depression with paroxetine but not with nefazodone. [2009.09]
Patient preference as a moderator of outcome for chronic forms of major depressive disorder treated with nefazodone, cognitive behavioral analysis system of psychotherapy, or their combination. [2009.01.13]
A meta-analysis of clinical trials comparing the serotonin (5HT)-2 receptor antagonists trazodone and nefazodone with selective serotonin reuptake inhibitors for the treatment of major depressive disorder. [2007.10]
Coadministration of nefazodone and desipramine: a pharmacokinetic interaction study. [2007.05]
Other possibly related research studies
Faster remission of chronic depression with combined psychotherapy and medication than with each therapy alone. [2008.06]
The impact of mental illness on sexual dysfunction. [2008]
Augmentation of antidepressants with atypical antipsychotics for treatment-resistant major depressive disorder. [2008.04]
Geometric mean IELT and premature ejaculation: appropriate statistics to avoid overestimation of treatment efficacy. [2008.02]
Antidepressant-induced liver injury. [2007.07]
[Applications and safety of modern antidepressants in patients with liver diseases] [2007]
Relationship between antidepressants and suicide attempts: an analysis of the Veterans Health Administration data sets. [2007.07]
The coprescription of contraindicated drugs with statins: continuing potential for increased risk of adverse events. [2007.01]
Caffeine metabolism during prolonged treatment of rats with antidepressant drugs. [2007.11]
Pharmacotherapy of methamphetamine addiction: an update. [2008]
Comparative benefits and harms of second-generation antidepressants: background paper for the American College of Physicians. [2008.11.18]
Using second-generation antidepressants to treat depressive disorders: a clinical practice guideline from the American College of Physicians. [2008.11.18]
Dyadic discord at baseline is associated with lack of remission in the acute treatment of chronic depression. [2009.07.17]
Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis. [2009.06]
Synergistic drug-cytokine induction of hepatocellular death as an in vitro approach for the study of inflammation-associated idiosyncratic drug hepatotoxicity. [2009.06.15]
Incidence of major malformations in infants following antidepressant exposure in pregnancy: results of a large prospective cohort study. [2009.04]
Depression in patients with heart failure: clinical implications and management. [2009.01]
Best practice guide for the treatment of nightmare disorder in adults. [2010.08.15]
Impact of depression and antidepressant treatment on heart rate variability: a review and meta-analysis. [2010.06.01]
Association between the use of serotonin receptor 2A-blocking antidepressants and joint disorders. [2009.10.15]
Interactions between herbal medicines and prescribed drugs: an updated systematic review. [2009]
Antidepressants for major depressive disorder and dysthymic disorder in patients with comorbid alcohol use disorders: a meta-analysis of placebo-controlled randomized trials. [2011.08]
Efficacy of antidepressants for dysthymia: a meta-analysis of placebo-controlled randomized trials. [2011.04]
Clinical and genetic correlates of suicidal ideation during antidepressant treatment in a depressed outpatient sample. [2011.03]
The use of monoamine pharmacological agents in the treatment of sexual dysfunction: evidence in the literature. [2011.04]
Case report: delirium due to a diltiazem-fentanyl CYP3A4 drug interaction. [2010.11]
Antidepressant drugs and breastfeeding: a review of the literature. [2011.04]
Managing menopausal symptoms and depression in tamoxifen users: implications of drug and medicinal interactions. [2010.12]
Efficacy of antidepressants: a re-analysis and re-interpretation of the Kirsch data. [2011.04]
Extrapyramidal symptoms associated with antidepressants--a review of the literature and an analysis of spontaneous reports. [2010.08]
Comparative effectiveness of second-generation antidepressants for accompanying
anxiety, insomnia, and pain in depressed patients: a systematic review. [2012]
Best practice guide for the treatment of nightmare disorder in adults. [2010]
Treatment of depression in patients from ethnic minority groups in the
Netherlands. [2010]
Differential effects of treatments for chronic depression: a latent growth model
reanalysis. [2010]
Dyadic discord at baseline is associated with lack of remission in the acute
treatment of chronic depression. [2010]
Strategies for managing sexual dysfunction induced by antidepressant medication. [2013]
|